JP2003267863A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003267863A5 JP2003267863A5 JP2002377732A JP2002377732A JP2003267863A5 JP 2003267863 A5 JP2003267863 A5 JP 2003267863A5 JP 2002377732 A JP2002377732 A JP 2002377732A JP 2002377732 A JP2002377732 A JP 2002377732A JP 2003267863 A5 JP2003267863 A5 JP 2003267863A5
- Authority
- JP
- Japan
- Prior art keywords
- heat shock
- shock protein
- geranylgeranylacetone
- protein inducer
- intracardiac
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims 5
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims 5
- 239000000411 inducer Substances 0.000 claims 4
- DJAHKBBSJCDSOZ-AJLBTXRUSA-N (5z,9e,13e)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one;(5e,9e,13e)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C/CCC(C)=O.CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CCC(C)=O DJAHKBBSJCDSOZ-AJLBTXRUSA-N 0.000 claims 3
- 229950006156 teprenone Drugs 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 2
- 101100507655 Canis lupus familiaris HSPA1 gene Proteins 0.000 claims 1
- 208000007201 Myocardial reperfusion injury Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 208000031225 myocardial ischemia Diseases 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002377732A JP2003267863A (ja) | 2002-01-09 | 2002-12-26 | 熱ショック蛋白質誘導剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002002835 | 2002-01-09 | ||
| JP2002-2835 | 2002-01-09 | ||
| JP2002377732A JP2003267863A (ja) | 2002-01-09 | 2002-12-26 | 熱ショック蛋白質誘導剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003267863A JP2003267863A (ja) | 2003-09-25 |
| JP2003267863A5 true JP2003267863A5 (https=) | 2005-10-27 |
Family
ID=29217822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002377732A Pending JP2003267863A (ja) | 2002-01-09 | 2002-12-26 | 熱ショック蛋白質誘導剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003267863A (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4601934B2 (ja) * | 2003-10-06 | 2010-12-22 | ナガセ医薬品株式会社 | ユビデカレノン錠 |
| WO2006062402A2 (en) * | 2004-12-10 | 2006-06-15 | Zernike Business Support B.V. | Heat shock proteins (hsp) and supraventricular arrhythmia |
| JP5027425B2 (ja) * | 2006-02-17 | 2012-09-19 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ゲラニルゲラニルアセトンを有効成分として含むチャンネル病治療剤 |
| JP5483513B1 (ja) * | 2013-02-19 | 2014-05-07 | ロート製薬株式会社 | 網膜疾患の予防、改善、又は治療用粘膜適用剤 |
-
2002
- 2002-12-26 JP JP2002377732A patent/JP2003267863A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003520232A5 (https=) | ||
| JP2005520796A5 (https=) | ||
| JP2019059760A5 (https=) | ||
| JP2003531157A5 (https=) | ||
| JP2003503454A5 (https=) | ||
| JP2006502236A5 (https=) | ||
| JP2005237328A5 (https=) | ||
| JP2005537234A5 (https=) | ||
| JP2004525194A5 (https=) | ||
| JP2006526590A5 (https=) | ||
| JP2007502287A5 (https=) | ||
| DE60229554D1 (de) | Verwendung von oxindol-derivaten bei der behandlung von demenzbedingten krankheiten, alzheimer-krankheit und erkrankungen im zusammenhang mit glykogen-synthase-kinase-3 | |
| JP2004002446A5 (https=) | ||
| JP2004506682A5 (https=) | ||
| JP2008513510A5 (https=) | ||
| JP2002542248A5 (https=) | ||
| JP2003526626A5 (https=) | ||
| JP2005511619A5 (https=) | ||
| NO20070522L (no) | Oral vedvarende frigivelsesformulering av tedisamil med gastriske bibeholdelsesegenskaper | |
| JP2003267863A5 (https=) | ||
| JP2018199643A5 (https=) | ||
| JP2006507295A5 (https=) | ||
| JP2005528357A5 (https=) | ||
| JP2008513426A5 (https=) | ||
| PE20051163A1 (es) | Formas de dosificacion oral de acido n-(2-(2-ftalimido-etoxi)-acetil)-l-alanil-d-glutamico (lk 423) |